BMC Cancer
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy.
24:984.
2024
-
A randomized control trial to compare mortality in recipients of leucoreduced and non-leucoreduced whole blood transfusion in patients with cancer in Uganda.
24:677.
2024
-
Physician-brief advice for promoting smoking cessation among cancer patients on treatment in low and middle-income countries: a scoping review.
24:149.
2024
-
Differences between physician and patient preferences for cancer treatments: a systematic review.
23:1126.
2023
-
A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol.
23:379.
2023
-
Correction to: Attention to principles of exercise training: an updated systematic review of randomized controlled trials in cancers other than breast and prostate.
22:182.
2022
-
PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial.
22:251.
2022
-
A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancer.
21:14.
2021
-
Attention to principles of exercise training: an updated systematic review of randomized controlled trials in cancers other than breast and prostate.
21:1179.
2021
-
Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
21:957.
2021
-
Antagonists of the serotonin receptor 5A target human breast tumor initiating cells.
20:724.
2020
-
Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
20:795.
2020
-
Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting.
20:798.
2020
-
Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
20:380.
2020
-
The relationship between physical activity and lymphoma: a systematic review and meta analysis.
20:962.
2020
-
Trajectories of physical activity, from young adulthood to older adulthood, and pancreatic cancer risk; a population-based case-control study in Ontario, Canada.
20:139.
2020
-
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
20:125.
2020
-
Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.
19:884.
2019
-
Attention to the principles of exercise training in exercise studies on prostate cancer survivors: a systematic review.
19:321.
2019
-
Breaking silence: a survey of barriers to goals of care discussions from the perspective of oncology practitioners.
19:130.
2019
-
Evaluation of an online knowledge translation intervention to promote cancer risk reduction behaviours: findings from a randomized controlled trial.
19:1138.
2019
-
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial.
19:582.
2019
-
Predictors of mammographic density among women with a strong family history of breast cancer.
19:631.
2019
-
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
19:816.
2019
-
Teetering on a liver’s edge: a case report highlighting clinical decision-making in thrombocytopenia.
19:1058.
2019
-
Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
18:1031.
2018
-
Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.
17:313.
2017
-
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures.
16:555.
2016
-
Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
15:882.
2015
-
Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model.
15:293.
2015
-
Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer.
14:871.
2014
-
Lack of treatment-related mortality definitions in clinical trials of children, adolescents and young adults with lymphomas, solid tumors and brain tumors: a systematic review.
14:612.
2014
-
Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’.
14:221.
2014
-
The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
14:415.
2014
-
A population-based study of rates of childbirth in recurrence-free female young adult survivors of Non-gynecologic malignancies.
13:30.
2013
-
Infections in pediatric acute promyelocytic leukemia: from the canadian infections in acute myeloid leukemia research group.
13:276.
2013
-
Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer.
13:76-76.
2013
-
Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?.
12:314.
2012
-
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
12:523.
2012
-
Systematic review: conservative treatments for secondary lymphedema.
12:6.
2012
-
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery.
11:291.
2011
-
Establishing a relationship between prolactin and altered fatty acid β-Oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
11:56.
2011
-
Cellular processes of v-Src transformation revealed by gene profiling of primary cells - Implications for human cancer.
10:41.
2010
-
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials.
10:675.
2010
-
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis.
9:34.
2009
-
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.
9:272.
2009
-
The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors.
9:356.
2009
-
Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis.
8:43.
2008
-
Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital.
6:263.
2006
-
Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
6:213.
2006
-
Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group.
6:112.
2006
-
The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study.
6:39.
2006
-
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
6:34.
2006
-
Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
5:17.
2005
-
Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases – an evidence-based practice guideline.
4:71.
2004
-
An evaluation of the integration of non-traditional learning tools into a community based breast and cervical cancer education program: The witness project of Buffalo.
3:18.
2003
-
Circulating soluble Fas levels and risk of ovarian cancer.
3:33.
2003
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)